Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients - Wikidata - awgldk - TriplyDB

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

http://www.wikidata.org/entity/Q37530591

about

Peptide-based vaccines for cancer therapy Trial watch: Dendritic cell-based anticancer therapy Phase I clinical trial of multiple-peptide vaccination for patients with advanced biliary tract cancer Induction and characterization of anti-tumor endothelium immunity elicited by ValloVax therapeutic cancer vaccine.Trial Watch: Peptide-based anticancer vaccines.The present status and future prospects of peptide-based cancer vaccines.A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma.Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8 Trial watch: Naked and vectored DNA-based anticancer vaccines Identification of the Key Fields and Their Key Technical Points of Oncology by Patent Analysis.Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.Cancer-testis antigens and immunotherapy in the light of cancer complexity.Pancreatic cancer: Update on immunotherapies and algenpantucel-L.Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapy.Emerging trends in the immunotherapy of pancreatic cancer.Present status and future perspective of peptide-based vaccine therapy for urological cancer.Functional analysis of KIF20A, a potential immunotherapeutic target for glioma.Immunotherapeutic Targeting of Tumor-Associated Blood Vessels.Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.

P2860

Q27022312-47ACEAE9-B2F8-4E61-A06A-7D18A8FA8150 Q27024047-B0988B60-E7FE-4AC6-869B-3B25235B0951 Q33587863-A9F4BE78-B307-461B-9B14-5FC262B3F534 Q33709802-A746BAD4-574F-4BF1-A461-2D924C50ADCE Q34483345-6530C829-6790-4B48-9590-B9F2F19E4815 Q34528638-F7C9E37C-3369-4A3B-A117-7669289919DA Q35201915-CE5518C1-9D77-412A-AC74-4F6FA70D7AA1 Q35724710-A30AC165-83E0-402F-85BD-807E7153C194 Q35798986-3CE1D1BB-682F-4EB6-803E-F5E0955072DC Q35850515-13BE1095-24F7-47F6-AD7E-97A096E43D76 Q35962063-64D1C178-3215-4347-AB74-AC69B9BD6C6E Q37414561-6F7942FF-D64E-43B0-92D0-12C31AFE1A04 Q37707523-AEC74786-7F1A-4C0D-9DF2-CBA3DECBE7EE Q38435410-5CCB6CFD-FAB6-4886-9E9C-D2725DB69C42 Q40261599-65C956FB-E60B-4F07-BD7B-A5CF34897B4D Q40279723-48FB6AA5-8C33-4564-9637-AA70F43E01E7 Q47248817-61B2FCE8-C66A-4244-86EE-7C2594846C4E Q47725715-A2732256-83E4-4E58-B5DA-DB480E7E043C Q48364471-34D71486-7BB4-409F-B0C0-2EF38F900712 Q49592831-927E5CF0-0E8F-426D-B6D9-2121F4DCDA5E Q49805542-8ACFEEAD-40DE-48F5-9D55-0AC824A29EF4

P2860

Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients

http://www.wikidata.org/entity/Q37530591

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Immunological responses to a m ...... ced pancreatic cancer patients

@en

Immunological responses to a m ...... ed pancreatic cancer patients.

@nl

type

label

Immunological responses to a m ...... ced pancreatic cancer patients

@en

Immunological responses to a m ...... ed pancreatic cancer patients.

@nl

prefLabel

Immunological responses to a m ...... ced pancreatic cancer patients

@en

Immunological responses to a m ...... ed pancreatic cancer patients.

@nl

P1433

Q37530591-0685F24E-BAF6-4D6C-B279-57824274249C

P1476

Q37530591-22F0923F-ACE7-46F7-BAF1-DB9104B627BC

P2093

Q37530591-22D4F691-3A03-4F37-B800-22926A9F8963

Q37530591-23335BF1-1F8F-4814-AE4A-D6E9E2D3D8E5

Q37530591-3741585F-CD2F-433F-BA7E-A2ABE09C17E3

Q37530591-4032C4EF-93A6-4521-8ED1-83E415E8A789

Q37530591-81BF4D67-69E5-42C0-BD33-44D609B36CB3

P2860

Q37530591-2B821564-45C6-46CE-9A6B-E17DC73C491D

Q37530591-3745FBE6-4290-47CA-981D-6117C6D8F305

Q37530591-4F25F394-B6A2-45B2-AF5A-06CF41185009

Q37530591-5332D3AA-85CD-44D6-BA6E-B554624C7D4C

Q37530591-560C3533-711E-4716-8DE4-AD18081D8722

Q37530591-62E506F6-76D9-4AE4-A758-C8DD240A73DC

Q37530591-6F707CA8-F475-4E58-89EE-9AB8FFB7B6F3

Q37530591-753D0262-9704-434B-B900-F45D1D8908FB

Q37530591-765C4AE1-6750-410A-B1DA-0BA163E47551

Q37530591-80EC9EA2-F25B-41BA-BACE-A29239DD3338

P304

Q37530591-E5AC91E7-0A89-48EC-BA4A-278A5794DF43

P31

Q37530591-035E9BB2-2CA3-4E2A-8FEA-F4FAD4501FF4

P356

Q37530591-B8E5B5C0-E387-4FB4-9083-DB603FA9A80B

P433

Q37530591-9D9457A1-7507-4B30-8437-DE010FF9A38C

P478

Q37530591-DA871BBD-DC83-4A28-8F68-B6C1BC0FF0D5

P577

Q37530591-92C7FA61-CB02-421C-97C3-7568D0E55C79

P5875

Q37530591-902B2942-FDC6-463B-B34D-A2AC8401EE5C

P698

Q37530591-D8B5134E-0573-4845-9446-7C5161D320DB

P921

Q37530591-F0D65E69-E6B8-4F0E-AE51-DD6FBCA14366

P932

Q37530591-B536B00D-14BF-422B-A483-D025C044369C

P356

P1433

P1476

Immunological responses to a m ...... ced pancreatic cancer patients

@en

P2093

Atsushi Aruga

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Takeda

http://www.w3.org/2001/XMLSchema#string

Masakazu Yamamoto

http://www.w3.org/2001/XMLSchema#string

Ryuji Okuyama

http://www.w3.org/2001/XMLSchema#string

Takashi Hatori

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Cancer peptide vaccine therapy developed from oncoantigens identified through genome-wide expression profile analysis for bladder cancer.

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.

Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer

P304

e27010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.27010

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260109474

http://www.w3.org/2001/XMLSchema#string

P698

24498547

http://www.w3.org/2001/XMLSchema#string

P921

P932

3906430

http://www.w3.org/2001/XMLSchema#string